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Abstract
Alveolar macrophages (AMϕs) secrete regulatory molecules that are believed to be critical in maintaining
normal lung homeostasis. However, in response to activating signals, AMϕs have been shown to become
highly phagocytic cells capable of secreting significant levels of pro-inflammatory cytokines. There is evidence
to suggest that susceptibility of Mϕ subpopulations to viral infection, and their subsequent cytokine/
chemokine response, is dependent on age of the host. In the present study, we compared bovine respiratory
syncytial virus (BRSV) replication and induction of cytokine responses in neonatal ovine AMϕs to those cells
isolated from adult animals. While neonatal AMϕs could be infected with BRSV, viral replication was limited
as previously shown for AMϕs from mature animals. Interestingly, following BRSV infection, peak mRNA
levels of IL-1β and IL-8 in neonatal AMϕ were several fold higher than levels induced in adult AMϕs. In
addition, peak mRNA expression for the cytokines examined occurred at earlier time points in neonatal
AMϕs compared to adult AMϕs. However, the data indicated that viral replication was not required for the
induction of specific cytokines in either neonatal or adult AMϕs. TLR3 and TLR4 agonists induced
significantly higher levels of cytokine transcripts than BRSV in both neonatal and adult AMϕs. It was recently
proposed that immaturity of the neonatal immune system extends from production of pro-inflammatory
cytokines to regulation of such responses. Differential regulation of cytokines in neonatal AMϕs compared to
adult AMϕs in response to RSV could be a contributory factor to more severe clinical episodes seen in
neonates.
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a b s t r a c t
Alveolar macrophages (AMs) secrete regulatory molecules that are believed to be critical
inmaintaining normal lung homeostasis. However, in response to activating signals, AMs
have been shown to become highly phagocytic cells capable of secreting signiﬁcant lev-
els of pro-inﬂammatory cytokines. There is evidence to suggest that susceptibility of M
subpopulations to viral infection, and their subsequent cytokine/chemokine response, is
dependent on age of the host. In the present study, we compared bovine respiratory syncy-
tial virus (BRSV) replication and induction of cytokine responses in neonatal ovine AMs to
those cells isolated from adult animals. While neonatal AMs could be infected with BRSV,
viral replication was limited as previously shown for AMs frommature animals. Interest-
ingly, following BRSV infection, peak mRNA levels of IL-1 and IL-8 in neonatal AMwere
several fold higher than levels induced in adult AMs. In addition, peak mRNA expression
for the cytokines examined occurred at earlier time points in neonatal AMs compared
to adult AMs. However, the data indicated that viral replication was not required for the
induction of speciﬁc cytokines in either neonatal or adult AMs. TLR3 and TLR4 agonists
induced signiﬁcantly higher levels of cytokine transcripts than BRSV in both neonatal and
adult AMs. It was recently proposed that immaturity of the neonatal immune system
extends from production of pro-inﬂammatory cytokines to regulation of such responses.
Differential regulation of cytokines in neonatal AMs compared to adult AMs in response
to RSV could be a contributory factor to more severe clinical episodes seen in neonates.
Published by Elsevier B.V.
1. Introduction
Infants and young children are commonly infected
with respiratory syncytial virus (RSV), which causes severe
lower respiratory tract infectionsmanifesting itself as acute
∗ Corresponding author at: Respiratory Diseases Research Unit,
National Animal Disease Center, ARS, USDA, 2300 Dayton Avenue, Ames,
IA 50010, United States. Tel.: +1 515 337 7354; fax: +1 515 337 7458.
E-mail address: randy.sacco@ars.usda.gov (R.E. Sacco).
bronchiolitis and pneumonia (Durbin and Durbin, 2004;
Welliver, 1983). Bovine respiratory syncytial virus (BRSV) is
a major etiological agent of lower respiratory tract disease
in calves (Van der Poel et al., 1994). RSV tropism for the
lower respiratory tract is supported by active replication
within lung epithelial cells, inducing production of media-
tors that are chemotactic to cells of the immune system.
Inﬁltration of antigen presenting cells, lymphocytes and
mononuclear cells is detected within lung tissue after RSV
infection (Kurlandskyet al., 1988;Trippet al., 1999).Within
the alveolar space, alveolar macrophages (AMs) play a
0165-2427/$ – see front matter. Published by Elsevier B.V.
doi:10.1016/j.vetimm.2010.02.008
56 S.J. Fach et al. / Veterinary Immunology and Immunopathology 136 (2010) 55–64
crucial role in clearance of respiratory pathogens as well
as the production of pro-inﬂammatory and immunomod-
ulatory mediators upon stimulation by microorganisms
(Wilmott et al., 2000). The presence of AMs in the lower
respiratory tract enables them to come in contactwith RSV.
In vivo data from adult humans conﬁrm the presence of
RSV within AMs of transplant patients (Panuska et al.,
1992). AMs infected in vitro with RSV has been docu-
mented in humans (Panuska et al., 1990), mice (Stadnyk
et al., 1997), guinea pigs (Dakhama et al., 1998), and calves
(Liu et al., 1999). Production of pro-inﬂammatory medi-
ators including IL-6, IL-8, TNF, and RANTES (Becker et
al., 1991; Franke-Ullmann et al., 1995; Kaan and Hegele,
2003; Miller et al., 2004), and immunomodulatory IL-10
(Panuska et al., 1995) have been described in RSV-infected
AMs. Recently, it was discovered that human AMs can
produce IL-4 after phorbol-12-myristate-13-acetate and
calcium ionophore stimulation (Pouliot et al., 2005). The
immunoregulatory mediators that are produced by AMs
make themacritical cell typewithakey role inhostdefense
and the early innate immune response to RSV.
Neonatal infants have an ineffective immune response
to RSV, as evidenced by the prevalence of recurrent infec-
tions during childhood (Henderson et al., 1979). Disease
manifestations in response to RSV infection vary greatly
among individual children. Childrenwith severe RSV infec-
tions were shown to have predominant type 2 cytokine
response leading to progression of the disease (Bendelja
et al., 2000; Roman et al., 1997). Older children and adults
generally exhibit mild symptoms. Similar age-dependency
in disease severity is seen in RSV infections in cattle and
sheep. In a previous study, we utilized an in vivo infec-
tionmodel to show that AMs isolated fromBRSV-infected
neonatal lambs express increased levels of IL-1, IL-4, IL-6,
IL-8, IL-10, and IL-12p40 mRNA transcripts compared to
control animals (Fach et al., 2007), similar to the afore-
mentioned ﬁndings reported in other host species. The
susceptibility of Ms to viral infection, and their subse-
quent response to infection, is likely dependent on age
of the host and differentiation stage of these myeloid lin-
eage cells. To our knowledge, there have been no direct
comparisons of neonatal and adult AM responses to
RSV infection. In the present study, we ﬁrst examined
whether neonatal and adult ovine AMs differed in per-
missiveness to viral infection. Next, we analyzed cytokine
transcriptional proﬁles induced in BRSV-infected AM iso-
lated from neonate or adult sheep. Finally, BRSV-induced
cytokine responses were compared to those induced by
UV-inactivated BRSV or TLR agonists (synthetic dsRNA
polyriboinosinic:polyribocytidylic acid (poly (I:C); TLR3) or
lipopolysaccharide (LPS; TLR4)).
2. Materials and methods
2.1. Viral inoculum
Bovine RSV strain 375 was propagated on adherent
bovine turbinate cells. By 7 days of incubation or when
over 90% of viral induced cytopathic effect was observed,
ﬂasks were frozen at −80 ◦C. Within 2 days, the ﬂasks
were thawed and all media pooled. After thorough mix-
ing and sterile ﬁltration, viral inoculum was aliquoted and
stored at −80 ◦C. Using a standard plaque assay, the tissue
culture infectious dosage (TCID50), for the virus was deter-
mined to be 104.9 TCID50/ml (3.97×104 plaque forming
units (pfu)/ml). The viral inoculumwas negative for bovine
viral diarrhea virus by PCR (not shown). For in vitro stud-
ies, BRSV strain 375was inactivated byUV irradiationusing
a Stratagene UV Stratalinker 1800 (3000W/cm2; Strata-
gene, La Jolla, CA) on the auto-crosslinkmode. Twenty-two
milliliters of BRSV 375 in a sterile 150mm×15mm petri
dish was irradiated 10 times, and the dish was gently
swirled each time in between treatments. Inactivation
of UV-BRSV was conﬁrmed by testing inoculum on fetal
bovine turbinate cells.
2.2. Isolation of alveolar macrophages (AMs)
Healthy 2–4-day-old lambs (n=8) and 2–9-year-old
adult sheep (n=7) of mixed Rambouillet and Polypay
breeds were used for the following experiments. At the
time of necropsy, the lungs were aseptically removed,
lavaged with sterile PBS and the collected cells were
pipetted into sterile 50ml conical tubes. Lavaged cells
were centrifuged at 805× g for 15min at 4 ◦C. The super-
natants were aspirated off and cells resuspended in
5ml of supplemented medium (SM; RPMI 1640 with 2%
lamb serum, 2mM l-glutamine, 25mM HEPES and 1%
antibiotic–antimycotic solution (all from Gibco, Carlsbad,
CA). Cells were transferred to a large (150mm×15mm)
sterile petri dish containing 30ml of SM. After 2h incuba-
tion at 5% CO2 and 37 ◦C, any non-adherent cells and the
media were aspirated off and adherent AMs washed in
warm, sterile PBS. The cells were released from the bottom
by the addition of PBS and gentle scraping with a sterile
rubber policeman. The AMs in PBS were pipetted into
50ml conical tubes and centrifuged at 453× g for 5min at
4 ◦C. The supernatants were aspirated off and AMs were
resuspended in 1–2ml of AMmedium then enumerated
on a hemacytometer.
2.3. In vitro stimulation of AMs
Sterile, ninety-six well round bottom plates were used
for the in vitro assays. AMs were adjusted to 1×106 cells
in 200L of SM. The cells were exposed to Escherichia
coli LPS O55:B5 (1g/ml; Sigma–Aldrich, St. Louis, MO),
poly (I:C) (1g/ml; Amersham Biosciences, Piscataway,
NJ), BRSV 375 at a multiplicity of infection (MOI) of 0.5,
1.0, or 2.0, or UV-inactivated BRSV 375 (UV-BRSV) at aMOI
of 1.0. After 90min of incubation, BRSV treated wells were
washed by aspiration of the supernatant and cells rinsed
with warm RPMI and 200L of fresh SM was replenished.
Supernatantswere collected and 300L of RLT buffer, from
the RNeasy Mini RNA Isolation Kit (Qiagen, Valencia, CA),
were added to cells and collected at 2, 6, 18 and 24h.
2.4. Immunohistochemistry
Alveolar macrophages (1×106 cells) were incubated
in chamber slides (Nalge Nunc International, Naperville,
IL) with 2ml SM and BRSV at a MOI of 1. After 90min
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incubation at 5% CO2 and 37 ◦C, any remaining extracel-
lular virus and medium was aspirated off and the cells
washed in warm RPMI. Two milliliters of fresh SM was
added to each chamber and slides were incubated at 5%
CO2 and 37 ◦C for a total of 24h. The medium was aspi-
rated off and the slides were washed with PBS and ﬁxed
for 10min with 100% methanol at room temperature. The
slides were dried and rehydrated in 1× Tris buffer and
blocked with normal goat serum (Kirkegaard Perry Labs,
Gaithersburg, MD) for 30min at room temperature. The
slides were washed in 1× Tris buffer and incubated with
polyclonal anti-BRSV antibody conjugated to FITC (50L;
VMRD Inc., Pullman, WA) at 37 ◦C for 30min. To visualize
nuclei, slides were washed with 1× Tris buffer and incu-
batedwith4′,6-diamidino-2-phenylindole, dilactate (DAPI,
300nM;Molecular Probes) for 5min at room temperature.
The slides were washed with 1× Tris buffer and cover slips
mounted with a 50–50 glycerin and PBS solution. Alveolar
macrophageswere examinedusing a Leica TCS-NTconfocal
scanning lasermicroscope (LeicaMicrosystems, Inc., Exton,
PA). Imageswere prepared using Adobe Photoshop version
CS and InDesign version 3.
2.5. RSV plaque assay
A previously published plaque assay (McKimm-
Breschkin, 2004) was utilized in the present study, with
the minor modiﬁcation that primary ovine fetal turbinate
epithelial (OFTu) cells were used as the cell type. This
was based on results of preliminary viral plaque experi-
ments comparing OFTu cells, bovine turbinate epithelial
cells, and human A549 cells. It was determined, that
for BRSV, OFTu cells gave the best plaque visualization.
Conﬂuent cells were inoculated with BRSV or super-
natants from BRSV-infected AMs and incubated for 1h
at 37 ◦C. The inoculum was removed and 3ml of overlay
(DMEM/F12+0.3% agarose) was added to each petri dish.
Samples were incubated up to 6 days at 37 ◦C, 5% CO2.
Subsequently, at selected time points postinoculation,
cells were ﬁxed overnight with 1% paraformaldehyde in
PBS. Following ﬁxation, agarose overlay was decanted,
plates rinsed with dH2O, and air-dried. Cells were stained
with 0.5% neutral red for 2h at RT, washed, and allowed to
air dry.
2.6. Total RNA extraction and cDNA synthesis
Enriched AMs were pelleted in sterile 1.5ml eppen-
dorf tubes. Cells were resuspended in 350L of RLT buffer
from the RNeasy Mini RNA Isolation Kit (Qiagen, Valen-
cia, CA) and stored at −80 ◦C. Total RNA was isolated using
the RNeasy Mini RNA Isolation Kit (Qiagen) according to
manufacturer’s instructions. Contaminating genomic DNA
was removed during RNA isolation using an on-column
RNase-Free DNase I digestion set (Qiagen) according to
manufacturer’s instructions. Total RNA was eluted by the
addition of 40L of DNase–RNase free water. 500ng to
1gof total RNA fromeach samplewas reverse transcribed
using oligo(dT)12–18 primers (Invitrogen, Carlsbad, CA).
2.7. Cytokine and BRSV NS2 mRNA real time PCR assays
Primers were designed speciﬁcally for SYBR Green
quantiﬁcation using the Primer Select program (DNASTAR
Inc., Madison, WI) with suggested parameters for SYBR
Green chemistry that included product size no larger than
100–150 base pairs and a 50 ◦C annealing temperature.
Ovine ribosomal protein S15 was chosen as the endoge-
Table 1
Primer sequences for ovine target and endogenous control genes.
Primer Sequence (5′–3′) Length (bp) Accession no.
IL-1 F ATGGGTGTTCTGCATGAG 63 X54796
IL-1 R AAGGCCACAGGAATCTTG
IL-4 F GGACTTGACAGGAATCTC 80 Z11897
IL-4 R CTCAGCGTACTTGTACTC
IL-6 F GAGTTGCAGAGCAGTATC 75 X62501
IL-6 R GGCTGGAGTGGTTATTAG
IL-8 F AAGCTGGCTGTTGCTCTC 94 X78306
IL-8 R GGCATCGAAGTTCTGTACTC
IL-10 F GATGCCACAGGCTGAGAACC 53 U11421
IL-10 R GCGAGTTCACGTGCTCCTTG
IL-12p40 F AAGTCACATGCCACAAGG 72 AF004024
IL-12p40 R CACTCCAGAATGAGCTGTAG
TNF F CTCATCTACTCGCAGGTCCTC 86 X56756
TNF R ACTGCAATGCGGCTGATGG
RiboS15 F TACAACGGCAAGACCTTCAACCAG 105 a
RiboS15 R GGGCCGGCCATGCTTTACG
BRSV NS2 F ACCACTGCTCAGAGATTG 155 NC 001989
NS2 R AATGTGGCCTGTCGTTCATCG
F= forward; R= reverse.
a Ovine ribosomal protein S15mRNAsequenceprovidedbyDr. Sean Limesand,Dept. of Pediatrics, University of ColoradoHealth SciencesCenter, Perinatal
Research Center, Aurora, CO.
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nous control for the genes of interest, which are listed
in Table 1. We have used S15 as our endogenous con-
trol in several previous publications (Fach et al., 2007;
Kawashima et al., 2006; Meyerholz et al., 2006; Sow et al.,
2009) and it was previously selected after comparisons to
-actin and GAPDH. In addition, primers were included for
a macrophage cell surface antigen, CD14, and cytokeratin
18. Cytokeratins are a subfamily of intermediate ﬁlament
proteins expressed in the intracytoplasmic cytoskeleton
of epithelia. Cytokeratin 18 was included to control for
epithelial cell contamination in the lavage cell preparation.
Cytokine mRNA transcripts were quantiﬁed as previously
described (Fach et al., 2007). Brieﬂy, Oligo(dT) cDNA was
diluted 1:10 in DNase–RNase free water and 2L used
for quantiﬁcation. SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA) was used according to man-
ufacturer’s instructions. An Applied Biosystems 7300 Real
Time PCR Systemsmachinewas usedwith the same ampli-
ﬁcation conditions for all genes of interest: 10min at 95 ◦C,
15 s at 95 ◦C, 40 cycles of 1min at 50 ◦C, with a dissoci-
ation step of 15 s at 95 ◦C, 30 s at 50 ◦C, 15 s at 95 ◦C. All
reactionswere performed in duplicate. Final relative quan-
tiﬁcation was calculated using the 2−CT method (Livak
and Schmittgen, 2001) where the amount of target gene
is normalized to an endogenous control (ovine ribosomal
protein S15) and expressed relative to control cells (Fach
et al., 2007). Primers were validated on the Applied Biosys-
tems 7300 machine by using serial dilutions of total RNA
with ovine ribosomal protein S15 and target gene primers,
whose values were plotted as the log input amount ver-
susCT values (target gene CT—endogenous control CT) for
relative efﬁciency. Only primers with a slope of less than
0.1 were used, due to similar ampliﬁcation efﬁciencies as
the endogenous control. Speciﬁcity of PCR products was
conﬁrmed by sequencing of amplicons.
In sterile eppendorf tubes, 20L of total RNA fromBRSV
375 inoculum and BRSV oligo(dT) cDNA were treated with
RNase If (1U/L; New England Biolabs, Ipswich, MA) or
untreated and all four samples were incubated for 30min
at 37 ◦C. The digestion of single stranded RNAwas stopped
by heating the tubes at 70 ◦C for 20min. Removal of the
RNase enzyme was performed by Microcon column exclu-
sion (100U columns; Millipore, Billerica, MA) according
to manufacturer’s instructions. Samples were quantiﬁed
using BRSV NS2 primers and SYBR Green chemistry as pre-
viously described (Fach et al., 2007), with the modiﬁcation
that subsequent time points were expressed relative to the
2h postinfection time point. No ampliﬁcation of genomic
BRSV NS2 was observed (not shown).
2.8. Statistical analysis
Data were expressed as a fold change relative to control
cells or, in the caseof BRSVNS2gene, relative to the2h time
point. We analyzed the cytokine data for each treatment
and gene with the outcome variable (2−CT) log trans-
formed. Samples were compared using a one-way ANOVA
(Prism, GraphPad, La Jolla, CA). Statistical signiﬁcance was
considered to be P<0.05.
3. Results
3.1. In vitro immunoﬂuorescence detection of
BRSV-infected AMs
To compare the permissiveness of neonatal and adult
AMs to BRSV infection, cells were exposed to virus at a
MOI of 2 for 90min. After 24h of incubation, slides were
ﬁxed and subsequently stained using a FITC-conjugated
anti-BRSV polyclonal antibody. A subpopulation of neona-
tal AMs expressed BRSV antigen as shown for two
individual animals (Fig. 1A and B). BRSV staining was
evident in the cytoplasm of infected AMs. Alveolar
macrophages not exposed to BRSV were included as neg-
ative controls as shown for one representative sample
(Fig. 1C). Similarly, a subpopulation of BRSV-infected adult
AMs expressed BRSV antigen as seen in neonatal lamb
AMs (not shown). Overall, AMs from both neonatal
lambs and adult sheep are permissive to BRSV infection
in vitro. However, additional experiments were utilized
to determine whether neonatal AMs differed from adult
AMs in supporting active viral replication after in vitro
BRSV infection.
3.2. Validation of BRSV NS2 real-time PCR using primary
cells
Upon initiation of replication, the RNA dependent RNA
polymerase transcribes the RSV negative sense genome
in the 3′ to 5′ direction. Large amounts of the nonstruc-
tural proteins NS1 and NS2 mRNA are produced during
viral replication, as a result of the genome’s transcriptional
polarity, where the genes on the 3′ end are transcribed
in greater amounts than 5′ genes. Primers were designed
to BRSV NS2 mRNA and a real-time PCR assay was used
as a measure of BRSV replication in adherent fetal ovine
turbinate cells. Data shown for each time point were nor-
malized using an endogenous control and expressed as a
fold increase relative to the 2h time point (Fig. 2A). As
can be seen, results of the real-time PCR assay indicated
that NS2mRNA increased in fetal turbinate cells over time.
Results of the NS2 real-time PCR assay correlate well with
results obtained using a viral plaque assay (Fig. 2B). Ear-
liest viral plaques were visible between days 3 and 4, but
were most clearly deﬁned by day 6 of incubation. The data
indicate that the NS2 real-time PCR assay can be used as a
measure of viral replication.
3.3. Neonatal AMs support limited viral replication in
vitro
To detect in vitro viral replicationwithinAMs, primers
were designed to the NS2mRNA of BRSV. Adult and neona-
tal AMs were exposed to BRSV in vitro for 90min and
the supernatant was removed. The cells were washed in
warm RPMI to remove any remaining extracellular viri-
ons and fresh medium was added. The supernatants and
cells were harvested after 2, 6, 18 and 24h of incubation.
Data from NS2 real-time PCR assay showed that neonatal
AMs incubatedwithBRSVexhibited little viral replication
and this did not vary signiﬁcantly with the different MOI
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Fig. 1. Bovine respiratory syncytial virus (BRSV) detection in neonatal AMs. Neonatal AMs were incubated in vitro with BRSV for 90min. Cells were
washedwithwarm RPMI and replenishedwith fresh completemedium. After 24h of incubation, cells werewashed and ﬁxed. Cells were stainedwith FITC-
labeled polyclonal anti-BRSV antibody and DAPI for nuclear visualization. Immunoﬂuorescence observed in BRSV-infected AMs from two representative
individual animals is shown (A and B). A representative micrograph from mock-infected AMs is shown in (C). Scale bars: 5M.
examined in the present study (Fig. 2C). If theNS2CT values
for BRSV were expressed relative to the CT values for UV-
inactivated virus therewas a signiﬁcant difference (P< .05),
but the fold change did not increase between 2 and 24h
(not shown). Adult AMs exposed to BRSV produced simi-
lar amounts of NS2 mRNAwhen compared to the neonatal
AMs exposed to BRSV (Fig. 2D). In either case, NS2 tran-
scription in BRSV-infected AMswas signiﬁcantly lower at
6 and 24h than observed for BRSV-infected epithelial cells
(Fig. 2A compared to Fig. 2C or D). The lack of evidence for
Fig. 2. Bovine respiratory syncytial virus (BRSV) replication in vitro. (A) Fetal ovine turbinate (OFTu) cells were exposed to BRSV and samples harvested
at the time points shown. BRSV NS2 mRNA induction was quantiﬁed by real-time PCR and data expressed relative to 2h time point. (B) Viral plaque assay
using OFTu cells exposed to BRSV. On days 4–6 postinfection, cells were ﬁxed, stained with 0.5% neutral red, washed and air-dried. Numbers in the upper
right corner are the average number of plaques per plate for duplicate samples. A mock-infected sample is presented for comparison. (C) Neonatal (n=8)
or (D) adult (n=7) AMs were exposed to BRSV at the indicated multiplicity of infection (MOI 0.5, 1.0 or 2.0) for 6, 18, or 24h. NS2 mRNA induction was
quantiﬁed using a real-time PCR assay and data expressed relative to 2h time point.
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Fig. 3. IL-1, IL-6, and IL-8 mRNA transcript expression in AMs in response to bovine respiratory syncytial virus (BRSV) or TLR ligation. Shown in each
panel are data for cells treated with BRSV (MOI =2), LPS (1g/ml), poly (I:C) (1g/ml), or UV-inactivated BRSV (MOI =1) for 2, 6, 18, or 24h. Total RNA
was isolated and cytokine induction was quantiﬁed by real-time PCR. Data for IL-1 (A), IL-6 (B), or IL-8 (C) are presented as means± standard errors of
the means relative to non-stimulated controls. Results for neonatal AMs (n=8) are shown in the left column, whereas results for adult AMs (n=7) are
shown in the right column. The dotted line in each panel denotes a 2-fold induction. ANOVA was used to compare TLR agonists or UV-inactivated BRSV to
live BRSV-stimulated cells within each panel for each cytokine (*P<0.05).
substantial viral replication in neonatal or adult AMs was
conﬁrmed by viral plaque assay using 24h supernatants
fromRSV-infectedAM cultures added toOFTu cells; there
were relatively few plaques observed following the 6-day
incubation period (not shown). Taken together, our results
indicate that neonatal AM do not support BRSV replica-
tion to a greater degree than adult AM as evidenced by
data from NS2 real-time PCR and viral plaque assays.
3.4. BRSV induces higher levels of vitro pro-inﬂammatory
cytokine transcripts in neonatal AMs compared to
mRNA levels induced in adult AMs
Alveolar Ms from neonatal lambs or adult sheep were
infected with BRSV and induction of cytokine gene expres-
sion at various time points postinfection was determined
using real-time PCR assays. To account for the potential for
epithelial cell contamination in lavage cell preparations,
we included primers for CD14 (macrophage marker) and
cytokeratin 18 (epithelial cell marker). AM cell prepa-
rations analyzed by RT-PCR did not contain a cytokeratin
18 amplicon, but an epithelial cell control was cytok-
eratin 18 positive (not shown). Thus, we did not ﬁnd
evidence for signiﬁcant contribution of epithelial cells to
adherent BAL cell-derived mRNA. The data shown herein
(Figs. 3–5) demonstrate that BRSV induced a quantita-
tively different cytokine mRNA response in neonates than
in adults. Of note, IL-1, IL-6, and IL-8 mRNA transcripts
were increased 4–20-fold upon viral infection of neonatal
AMs (Fig. 3A–C). However, these responses in neonatal
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Fig. 4. IL-12p40 and TNF-mRNA transcripts expression in AMs in response to bovine respiratory syncytial virus (BRSV) or TLR ligation. Shown in each
panel are data for cells treated with BRSV (MOI =2), LPS (1g/ml), poly (I:C) (1g/ml), or UV-inactivated BRSV (MOI =1) for 2, 6, 18, or 24h. Total RNA
was isolated and cytokine induction was quantiﬁed by real-time PCR. Data for IL-12p40 (A) or TNF- (B) are presented as means± standard errors of the
means relative to non-stimulated controls. Results for neonatal AMs (n=8) are shown in the left column, whereas results for adult AMs (n=7) are shown
in the right column. The dotted line in each panel denotes a 2-fold induction. ANOVA was used to compare TLR agonists or UV-inactivated BRSV to live
BRSV-stimulated cells within each panel for each cytokine (*P<0.05).
AM peaked early and were not sustained, similar to the
previous report of Matsuda et al. (1996) showing short-
term expression of IL-6 or TNF- in neonatal cord blood
monocyte-derived macrophages. By comparison, a 1–4-
fold increase in transcripts for IL-1, IL-6 and IL-8 were
observed in adult AMs. In general, pro-inﬂammatory IL-
12p40 and TNF gene transcription increased 2–4-fold
after BRSV infection of neonatal and adult AMs (Fig. 4A
and B). For the time points examined, transcription of
IL-4 and IL-10 peaked at 6h postinfection in neonates,
but peaked at later time points postinfection in adults
(Fig. 5A and B). Interestingly, AMs exposed to either live
BRSV or UV-BRSV expressed similar levels of mRNA tran-
scripts of IL-1, IL-4, IL-6, IL-10, IL-12p40, and TNF. By
comparison, UV-BRSV actually induced signiﬁcantly more
IL-8 gene transcription than live BRSV in neonatal AMs.
Thus, it is likely that phagocytosis of small numbers of
RSV virions would be sufﬁcient to trigger an induction of
cytokines/chemokines in neonatal AMs.
3.5. TLR agonists induced higher levels of cytokine
transcripts in neonatal ovine AMs compared to mRNA
levels induced in AMs from adult animals
LPS is a known inducer of TLR4 signaling and poly
I:C (synthetic double stranded RNA) has been shown to
signal through TLR3. Data from in previous studies have
suggested thatRSVmay inducecytokineproductionvia sig-
naling pathways dependent on TLR3 (Rudd et al., 2005) or
TLR4 signaling (Kurt-Jones et al., 2000). Therefore, wewere
interested to compare responses from AMs stimulated
with LPS or poly I:C to responses induced by BRSV. Induc-
tion of cytokine gene expression at various time points
postinfection was determined using real-time PCR assays.
In the present experiments, TLR3 or TLR4 agonists induced
signiﬁcantly higher levels of IL-1, IL-6, IL-8, IL-10 and IL-
12p40 gene transcription in neonatal and adult AMs in
comparison to the levels of transcription induced by BRSV
infection (Figs. 3–5). Moreover, the cytokine induction to
TLR agonists was sustained in neonatal AMs, whereas the
induced cytokine response to BRSV was generally not. In
addition, as described for BRSV above, TLR-stimulation of
AMs isolated from neonates generally exhibited levels
of mRNA transcription that exceeded levels seen in adult
AMs. Of note, levels of peak induction varied based on the
speciﬁc cytokine examined, the agonist used for stimula-
tion, andageofhost fromwhichAMswere isolated. Taken
together, our results indicate that cytokine/chemokine
mRNA expression induced in neonatal AMs via TLR3 or
TLR4 ligation or BRSV infection was, in general, substan-
tially higher than mRNA transcript levels induced in adult
AMs.
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Fig. 5. IL-4 and IL-10 mRNA transcripts expression in AMs in response to bovine respiratory syncytial virus (BRSV) or TLR ligation. Shown in each panel
are data for cells treated with BRSV (MOI =2), LPS (1g/ml), poly (I:C) (1g/ml), or UV-inactivated BRSV (MOI =1) for 2, 6, 18, or 24h. Total RNA was
isolated and cytokine induction was quantiﬁed by real-time PCR. Data for IL-4 (A) or IL-10 (B) are presented as means± standard errors of the means
relative to non-stimulated controls. Results for neonatal AMs (n=8) are shown in the left column, whereas results for adult AMs (n=7) are shown in
the right column. The dotted line in each panel denotes a two-fold induction. ANOVA was used to compare TLR agonists or UV-inactivated BRSV to live
BRSV-stimulated cells within each panel for each cytokine (*P<0.05).
4. Discussion
The present study is the ﬁrst to directly compare BRSV
infection or TLR ligation and subsequent induction of
cytokine responses in neonatal AM to cells isolated from
adult animals. Neonatal and adult AMs were permis-
sive to BRSV, however, the virus was demonstrated to
minimally replicate within these cells. In general, adult
AMs produced lower levels of cytokinemRNA transcripts
after in vitro BRSV infection compared to cytokine tran-
scripts seen in the neonatal AMs, especially IL-1 and
IL-8 at the peak of their respective responses. Furthermore,
peak cytokine mRNA expression occurred at earlier time
points in neonatal AMs compared to peak cytokinemRNA
expression in adult AMs. Finally, TLR3 and TLR4 agonists
induced quantitatively higher levels of pro-inﬂammatory
and immunomodulatory cytokine responses than BRSV in
both neonatal and adult AMs.
Prior investigators have shown that adult AMs can
be infected with RSV, but viral replication is generally
abortive. Given that neonates exhibit greater susceptibil-
ity to RSV infection, a key parameter to evaluate would be
permissiveness of neonatal AMs to RSV infection com-
pared to cells from adults. To investigate viral infection of
AMs, in vitro assays utilizing neonatal lamb AMs inoc-
ulated with BRSV were established for direct comparison
to responses induced in adult AMs. In vitro studies were
necessary since immunocompetent adults are generally
not susceptible to RSV. Detection of macrophage infec-
tion was determined by immunoﬂuorscence microscopy.
The immunoﬂuorescence data shows that different sub-
sets of neonatal AMs are permissive to RSV infection. To
date, it remains unknownwhy someAMs are not infected
with the virus, but one study suggests that the matura-
tion state of AMs may inﬂuence susceptibility to RSV,
with immature AMs more permissive to RSV infection
(Dakhamaet al., 1998).Nonetheless,weobserved thatmin-
imal replication of BRSV occurred in both neonatal lamb
and adult sheep AMs infected with the virus in vitro, in
agreementwith previous studies of adult AMs fromother
species (Franke-Ullmann et al., 1995; Stadnyk et al., 1997).
We have demonstrated this by two different approaches;
utilizing real-time PCR detection of viral NS2 mRNA or a
viral plaque assay using supernatants from AM cultures.
Further, we have shown that live virus is generally not
required for cytokine mRNA induction. Therefore, differ-
ences in cytokine transcriptional proﬁles induced by RSV
in neonatal AMs compared to adult AMs are not a direct
result of differences in viral replication.
Previous studies have reported production of pro-
inﬂammatory cytokines and chemokines from AMs
infected in vitro with RSV. Human, mouse, calf, or guinea
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pig AMs have been utilized for these in vitro assays. Pro-
duction of IL-1, IL-6, IL-8, and TNF mRNA and protein
is seen in AMs after infection with RSV (Becker et al.,
1991; Franke-Ullmann et al., 1995; Kaan andHegele, 2003;
Panuska et al., 1995). However, AMs utilized in previous
studies were isolated from different aged subjects, some
using adult human, or adult or juvenile laboratory animals
for their studies (Becker et al., 1991; Kaan and Hegele,
2003; Miller et al., 2004; Stadnyk et al., 1997). We are
aware of studies in which investigators compared neona-
tal and adult macrophage responses to RSV. However, in
those studies, the authors utilized neonatal cord blood-
derived and adult peripheral blood-derivedMs (Krishnan
et al., 2003; Matsuda et al., 1996; Midulla et al., 1989).
Midulla et al. (1989) did examine alveolar macrophages
in their study, but only isolated these cells from adult
subjects. Our study, for the ﬁrst time, compares neonate
and adult AMs in parallel to examine the RSV modula-
tion of cytokinemRNA transcripts. Both neonatal and adult
AMs produced at least a 2-fold increase in gene expres-
sion of IL-1, IL-4, IL-6, IL-8, IL-10, IL-12p40 and TNF in
response to BRSV. However, IL-1 and IL-8 at the peak of
their respective responses were found to be several fold
higher in neonatal AMs than in adult cells. In agree-
ment with our ﬁndings, it has been shown that neonatal
mice have stronger pro-inﬂammatory cytokine responses
to viral infection than adult mice (Zhao et al., 2008). More-
over, it is interesting to note that IL-1 and IL-8were found
to be the major inﬂammatory mediators in bronchoalveo-
lar lavageﬂuidof childrenwithchronic respiratorydiseases
(Babu et al., 2004). IL-1 has numerous pro-inﬂammatory
effects, including induction of chemokines in bronchial
epithelial cells and airway smooth muscle (Edwards et al.,
2005; Oltmanns et al., 2003; Wuyts et al., 2003). In RSV ill-
nesses in infants, there is a marked increase in neutrophil
numbers which is associated with increased levels of IL-8
(Noah et al., 2002).
Discrepancies exist in the literature as to whether live,
replicating virus is needed for cytokine induction. In the
present study, results indicate that in vitro BRSV repli-
cation is not necessary for induction of cytokine gene
expression in neonatal or adult AMs. Our results are in
agreement with previous studies that reported IL-6, IL-8,
and TNF expression is induced by live RSV and UV- or
heat-inactivated RSV exposed human or murine primary
AMs (Becker et al., 1991; Stadnyk et al., 1997). How-
ever, these observations are in contrast to one reportwhere
investigators using amurineAM cell line showed that live
RSV is required for optimal chemokine induction (Miller et
al., 2004). This discrepancybetween theobservations in the
study of Miller et al. (2004) and results from other studies,
including our own, may plausibly be explained as a differ-
ence due to the use of an AM cell line versus the use of
primary AMs.
In the present study we quantitatively compared BRSV
modulated cytokine gene transcription in AMs to that
induced by TLR3 and TLR4 agonists. Recently, one study
has reported RSV induces chemokine production of IL-8
and RANTES via TLR3 signaling in vitro using transfected
TLR3 HEK 293 cells (Rudd et al., 2005). RSV was also
shown to up regulate expression of TLR3 on epithelial
cell lines. TLR3 engagement initiates cytoplasmic recruit-
mentof TRIF, leading todownstreamactivationandnuclear
translocation of NF-B family members and transcription
of pro-inﬂammatory genes (O’Neill, 2006). Other studies
have investigated the interaction of RSV and TLR4. Engage-
ment of TLR4 by afﬁnity puriﬁed RSV A2 F proteins has
been shown in vitro to stimulate production of IL-6 by
human monocytes and peritoneal macrophages, though
it is unknown whether this occurs speciﬁcally on AMs
since they were not examined in these studies (Kurt-
Jones et al., 2000). TLR4 stimulation leads to activation
of either MyD88 dependent or independent pathways,
subsequent activation of NF-B family members, and ulti-
mately the transcription of pro-inﬂammatory mediators
(O’Neill, 2006). While studies have demonstrated that
RSV activates NF-B via TLR signaling in epithelial cells,
cytokine responses of lung APCs to RSV and TLR ago-
nists have not been compared in parallel. Since RSV may
potentially interact with TLR3 and TLR4, it was reason-
able to compare the cytokine response elicited by BRSV
infection compared to TLR3 or TLR4 stimulation of AMs.
The data in the present study demonstrate that although
BRSV induced an upregulation in the cytokine/chemokine
response in AMs, modest mRNA transcription was gen-
erally observed when compared to that induced via TLR
ligation. More importantly, TLR signaling induced higher
levels of cytokine transcripts in neonatal AMs compared
to the induction in adult AMs. This data ﬁtswell with pre-
vious published results showing that neonatal mice have
higher inﬂammatory responses to LPS and poly (I:C) than
do adult mice (Zhao et al., 2008). They recently proposed
that immaturity of the neonatal immune system extends
from production of pro-inﬂammatory cytokines to regula-
tion of such responses. Based on these observations, it will
be of interest todelineatemechanisms involved in cytokine
transcriptional regulation in neonatal AMs compared to
adult AMs.
Host cellular recognition of pathogenicmicroorganisms
activates signaling modules that are critically involved in
regulating cytokine and chemokine induction within the
lungmicroenvironment. Cytokineandchemokinecrosstalk
in the lung between epithelial cells, professional anti-
gen presenting cells, and other immune cells is important
in the outcome and severity of RSV pathogenesis. We
have shown a differential induction of the cytokine tran-
scriptional response to RSV infection in neonatal AMs
compared to AMs isolated from adults. Macrophages
may be a predominant cell population contributing to
severe immunopathology seen in respiratory viral infec-
tions. Differential pro-inﬂammatory cytokine regulation in
neonatalmyeloid lineage cells compared to analogous cells
in adults could contribute to variances in responses to RSV
infection.
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